Introduction to Pharmacology Flashcards
(50 cards)
Define pharmacokinetics
What the body does to the drug
Define pharmacodynamics
What the drug does to the body
Define drug
a chemical substance of known structure, which when administered to a living organism produces a biological effect
Define medicine
Usually, but not necessarily contains one or more drug, which is administered with the intention of producing a therapeutic effect
Define therapeutics
Use of drugs to diagnoses, prevent, and treat illness
Define formulations
how the drug is packaged
Define excipients
substances formulate alongside the drug
Define medicinal product
any substance or combination of substances presented as having properties of preventing or treating disease in humans
What are a drugs 3 names?
Chemical = chemical structure Generic = class of drug Proprietary = trade name
What is a lignad?
a molecule that binds to the receptor
What is a receptor?
a molecular target for a drug
What is an agonist?
a molecule that activates a receptor
What is an antagonist?
something that blocks or reduces agonist mediated responses
What is an analgesic?
an objective treatment in all types of pain, irrespective of its origin, to achieve symptom control and improve quality of life - relieves or reduced pain
Explain what a ligand is and what it does?
Ligands are a molecule that binds to the receptor. They can be exogenous (outside human body), or endogenous (inside human body). A ligand might be a drug, a neurotransmitter, or a hormone. Ligands can act on different receptors, and they can be synthetic or natural drugs.
What is a target?
A molecule, usually a protein, that is accessed by a drug to produce a therapeutic effect
What would an ideal drug look like?
A drug with a desirable pharmacological action, with acceptable or no side effects, reaches its target in the right concentration at the right time, remains at the site of action for sufficient time, and be rapidly and completely removed from the body when no longer needed.
Explain how drugs produce effects and key aspects of drug binding.
Drugs usually interact in a structurally specific way with its target. Drugs bind like a lock and key. The shape of the drug binds specifically with their receptor, the physical shape of the drug is compatible with the receptors shape. Local electrostatic charges on the receptor and ligand are also important in binding. Opposite charges attract, and drug and receptor have different charges to be able to attract and attach. Therefore, the physico-chemical properties and steric properties affect drug receptor binding.
What is affinity?
How well the ligand binds to the receptor
What are the common protein targets?
Receptors, ion channels, carrier molecules and enzymes (RICE)
What is the receptors role?
It is the biologically relevant molecular site with which a drug binds to produce a response. The endogenous ligand and exogenous ligand activates the receptor. The ligand binds to the receptor and alters the receptor conformation. This activates the intracellular second messenger cascade, which creates diverse intracellular effects such as cellular excitability. The modulation of other ion channels are created, and the down-regulation of G-protein linked receptors.
What is the role of carrier proteins/transporters?
These are the facilitators for transport for example across membranes. Activate transporters which require ATP and facilitate diffusion.
What is the role of enzymes?
Enzymes inhibitors bind to the enzyme and act as a substrate analogue, where they inhibit or block the enzymes normal activity by the drug. False substrate are drugs that bind to the enzyme and produce an abnormal metabolite. Pro-drug are drugs that bind to the enzymes and produce an active drug, can be activated by enzymes in the body
Explain drug specificity
The binding site specificity is a key feature but no drugs act with complete specificity. Non specific interactions are very possible and highly likely, only some drugs will target one specific place in the body. A drug may preferentially bind to a promiscuous and bind to other targets. More likelihood of non-specific interactions becoming significant with larger doses.